DEXACORT Drug Patent Profile
✉ Email this page to a colleague
When do Dexacort patents expire, and what generic alternatives are available?
Dexacort is a drug marketed by Ucb Inc and is included in two NDAs.
The generic ingredient in DEXACORT is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexacort
A generic version of DEXACORT was approved as dexamethasone sodium phosphate by WEST-WARD PHARMS INT on September 7th, 1982.
Summary for DEXACORT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 115 |
Clinical Trials: | 1 |
Patent Applications: | 4,552 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXACORT at DailyMed |
Recent Clinical Trials for DEXACORT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tel-Aviv Sourasky Medical Center | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for DEXACORT
US Patents and Regulatory Information for DEXACORT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ucb Inc | DEXACORT | dexamethasone sodium phosphate | AEROSOL, METERED;INHALATION | 013413-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ucb Inc | DEXACORT | dexamethasone sodium phosphate | AEROSOL;NASAL | 014242-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |